Changes in the expression of NIK mRNA and protein were determined before and after treatment with methylprednisolone. Briefly, freshly obtained muscle biopsy sample (0.05 to 0.2g) was digested by dispase II and collagenase for 40 minutes at 37° C, and then filtered through 40-μm cell strainer. NF-κB–inducing kinase (NIK) is an upstream NF-κB pathway activating kinase, tightly regulated by cells to maintain low basal levels. NF-κB signaling plays a prominent role in skeletal muscle atrophy, and pro-inflammatory cytokines induce skeletal muscle atrophy through downstream signaling requiring RelA/p65 (10). From a descriptive/histological point of view, sarcopenia induces a change in the proportion of skeletal muscle fibers, inducing a shift from type II (fast) to type I (slow) fibers as well as preferential loss of type II fibers (22). Clinical studies of androgen supplementation in age-related diseases and muscle wasting are a focus of emerging interest (11). If you’ve experienced muscle weakness, loss of endurance or any other symptoms of sarcopenia, call your healthcare provider. Everyone loses muscle mass over time, but people with sarcopenia lose it more quickly. Intrinsic factors leading to alterations in skeletal muscle involve various intracellular signaling pathways, which in turn may activate intracellular modulators in a manner that has long-term cellular effects. In a study using cultured myotubes, Li et al. detected NF-κB mediated up-regulation of UbcH2 at the mRNA level after 90 min of TNF-α stimulation and at the protein level after 4 h of stimulation, as well as an increase in ubiquitin-conjugating activity after 4–6 h of stimulation to a level that remained elevated for at least 24 h (46). In rat myotubes, a type of "immature" muscle fiber, our group recently observed rapid phosphorylation of Akt via phosphatidylinositol-3 kinase (PI3K) and subsequent phosphorylation of mammalian target of rapamycin (mTOR), which lies upstream of the critical translation regulator 40S ribosomal protein S6 kinase 1 (S6K1), to increase protein synthesis (38). Research to date indicates that testosterone stimulates protein synthesis by both a short-term mechanism-rapid activation of pre-existing components of the translational apparatus- and a long-term mechanism-increase in cell or tissue capacity at the protein synthesis level leading to increase in ribosome quantity (36). Specifically, they found that men with low free testosterone levels were 57% more likely to develop mobility limitation and 68% to experience increase in mobility limitation compared to men with normal testosterone levels. Androgen supplementation has been observed to exert anabolic actions that enhance muscle strength and increase muscle size clinically (27–31). Clinical studies reveal that sarcopenia is a main cause of higher frailty, impairment, and loss of independence in elderly women than men (18). This narrative review aims to show the relationship between the decline in testosterone with age, sarcopenia, and frailty, as well as the effects of testosterone replacement therapy on muscle mass and strength. Many studies reporting an increase in muscle strength with TRT suffered from methodological problems, such as lack of a control group, lack of control for the effects of exercise, lack of control of the dose(s) of the hormones administered to maintain normal levels of circulating testosterone, or the inclusion of a very small number of patients. There is consensus that the use of testosterone leads ultimately to regulate skeletal muscle mass by a net increase in protein synthesis over degradation. While elevated plasma androgen concentrations are known to induce skeletal muscle hypertrophy (35), the cellular mechanisms by which testosterone increases skeletal muscle mass remain under investigation. Because testosterone is the main physiological anabolic hormone, a decline in its plasma concentrations by age must be considered one of the causes for loss of muscle mass and an extrinsic factor for sarcopenia. In addition to a natural decrease in testosterone levels due to age, abnormal levels of plasma testosterone are observed in men suffering from late-onset hypogonadism, loss of testicular mass, and endocrine diseases involving low androgen production, accelerated testosterone metabolism or malfunctioning androgen receptor (24, 25). The medical definition of sarcopenia is the gradual loss of muscle mass, strength and function. The satellite cells are myogenic precursors capable of regenerating skeletal muscle and demonstrate self-renewal properties. Several reports indicate that it is possible to isolate stem cells from adult skeletal muscle, but is important to distinguish between satellite cells and muscle-derived stem cells (MDSC). The sarcopenic process is more pronounced in patients showing significant loss of muscle stem cells, particularly satellite cells. Its importance is evidenced by observation of significant age-related decreases in levels of MIP mRNA, protein content, and activity in wild-type mice. This complex process of Ca2+ signaling, which depends on the interplay between IP3-sensitive stores and extracellular Ca2+ influx, is unaffected by the androgen-receptor antagonist cyproterone acetate, and apparently mediated by a pertussis toxin-sensitive G protein-coupled membrane receptor activated by testosterone 3-(O-carboxymethyl)oxime (T-BSA). In skeletal muscle, we observed that testosterone stimulation induces rapid (2+ signals, which begin as Ca2+ transients initiated in the cytosol before being propagated as waves of Ca2+ in the cytoplasm and nucleus (68, 70, 71). In soleus muscle of sedentary volunteers, Delgado et al. observed that administration of stanozolol, an anabolic steroid derivate, increased SOD, and glutathione reductase activities, but induced no change in other enzyme activities as catalase and glutathione peroxidase (53).
.jpg)
